Glioblastoma Multiforme (GBM) Treatment Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Glioblastoma Multiforme (GBM) Treatment Market Valuation Change Between Now And 2029?
The market scale of glioblastoma multiforme (gbm) treatment has seen a robust growth lately. It is set to expand from $2.48 billion in 2024 to reach $2.73 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.8%. Factors contributing to the growth during the historic period include a rise in incidence and prevalence, progress in diagnostic methods, funding for clinical trials and research, collaborations and partnerships, along with a better comprehension of tumor biology.
Anticipated to experience swift expansion in upcoming years, the glioblastoma multiforme (gbm) treatment market is predicted to reach $4.06 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.5%. This growth trajectory during the forecast period can be linked to the introduction of immunotherapies, advancements in precision medicine, a broader understanding of genetic markers, increased patient advocacy and awareness, as well as government backing for rare diseases. The period is also set to witness significant trends such as the exploration of combination therapies, the incorporation of artificial intelligence in diagnosis and treatment schemes, the growing acceptance of immunotherapeutic methods, along with the advancements in medical tools and apparatus.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8803&type=smp
What Underlying Factors Are Supporting The Glioblastoma Multiforme (GBM) Treatment Market Growth?
The upwards trend in brain disorders is anticipated to spur the expansion of the glioblastoma multiforme (GBM) treatment market in the future. Brain disorders include abnormal operations of the brain, nerves spanning the human body, and the spinal cord. Various factors contribute to the rising incidence of brain disorders like glioblastoma multiforme (GBM) including an ageing population, weakened immune systems, overdiagnosis, ionizing radiation, air pollution, and others. This increase necessitates treatments to enhance the quality of life. A study by the American Cancer Society, a voluntary health organization in the US committed to eradicating cancer, revealed that around 25,050 malignant brain or spinal cord cancer instances were identified in the US in 2022. Consequently, this rising prevalence of brain disorders is fuelling the expansion of the glioblastoma multiforme (GBM) treatment market.
Which Sub-Segments Are Driving Growth Within The Glioblastoma Multiforme (GBM) Treatment Market?
The glioblastoma multiforme (gbm) treatmentmarket covered in this report is segmented –
1) By Treatment: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Tumor Treating Field (TTF) Therapy; Immunotherapy
2) By Drug Class: Temozolomide; Bevacizumab; Lomustine; Carmustine Wafers; Other Drug Classes
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By End-Use: Hospitals; Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Surgery: Tumor Resection; Biopsy Procedures
2) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Stereotactic Radiation Therapy
3) By Chemotherapy: Standard Chemotherapy; Combination Chemotherapy Regimens
4) By Targeted Therapy: EGFR Inhibitors; Other Targeted Agents
5) By Tumor Treating Field (TTF) Therapy: Device-Based TTF Treatment
6) By Immunotherapy: Checkpoint Inhibitors; Vaccine-Based Therapies
What Key Trends Are Driving Growth In The Glioblastoma Multiforme (GBM) Treatment Market?
Leading players in the market are focusing on the creation of novel, wearable, and portable devices to maintain their market dominance. Their efforts are primarily directed towards providing users with increased functionality, convenience, and ease-of-use, in response to the escalating demand for accessible and effective healthcare systems. For example, in 2023, Novocure, an oncology company from Jersey, introduced Optune Gio, an FDA-approved wearable and portable treatment solution for patients recently diagnosed with glioblastoma (GBM). The device uses Tumor Treating Fields (TTFields), which are fluctuating electric fields that inhibit the division of cancer cells, potentially enhancing the longevity of the patients. The Optune Gio weighs just 2.7 pounds, ensuring comfort and adaptability that allows patients to wear it during their routine tasks.
Which Companies Hold A Competitive Edge In The 431 Market?
Major companies operating in the glioblastoma multiforme (GBM) treatment market include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Jazz Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Varian Medical Systems Inc., Amneal Pharmaceuticals Inc., Elekta AB, ANI Pharmaceuticals Inc., Accord Healthcare Limited, The Eckert & Ziegler Group, Loxo Oncology Inc., Karyopharm Therapeutics Inc., Celon Laboratories Pvt. Ltd., EnGeneIC Ltd., Zydus Pharmaceuticals Inc., Genenta Science S.r.l., Cantex Pharmaceuticals Inc., Vascular Biogenics Ltd., Seelos Therapeutics Inc, Angiochem Inc., Diffusion Pharmaceuticals Inc.
Access The Complete Report Here:
Which Region Dominates The Glioblastoma Multiforme (GBM) Treatment Market Today?
North America was the largest region in the glioblastoma multiforme (GBM) treatment market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glioblastoma multiforme (gbm) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=8803&type=smp
Browse Through More Reports Similar to the Global Glioblastoma Multiforme (GBM) Treatment Market 2025, By The Business Research Company
Neurology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Neurophysiology Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
